Legal Representation
Attorney
Terry M. Gernstein
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 9, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 9, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 7, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 15, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 25, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 21, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 21, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 26, 2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 26, 2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 26, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 26, 2007 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Feb 22, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 17, 2006 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 12, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals, namely an injectable and aerosolized Type 5 phosphodiesterase inhibitor used to prolong the effects of nitric oxide gas
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005